Adamis Pharmaceuticals Corp (ADMP) CEO Dennis Carlo on Q3 2019 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) Q3 2019 Earnings Conference Call November 12, 2019 5:00 PM ET

Company Participants

Dennis Carlo - President, CEO & Director

Robert Hopkins - SVP, Finance, CFO & Secretary

Ronald Moss - Chief Medical Officer

David Marguglio - SVP, Chief Business Officer & Director

Conference Call Participants

Elliot Wilbur - Raymond James & Associates

Jason McCarthy - Maxim Group


Good day and welcome to the Adamis Pharmaceuticals Corp. Third Quarter 2019 Conference Call. Today's conference is being recorded.

At this time, I would like to turn the conference over to Dr. Dennis Carlo, President and CEO. Please go ahead, sir.

Dennis Carlo

Thank you. I'm Dennis Carlo, President and CEO of Adamis. Thank you for joining us today for the update, and welcome to our shareholders, analysts and anyone new to Adamis. Joining me today is our Chief Financial Officer, Rob Hopkins; our Chief Medical Officer, Dr. Ronald Moss; and our Chief Business Officer, David Marguglio.

Once again, the format for this call will consist of some remarks from management followed by an opportunity for some questions. This call is being webcast and will be available for replay in the Investors section of our website, I will remind everyone that in today's call, we will make certain forward-looking statements regarding our business based on current expectations and current information. Those statements speak only as of today, and except as required by law, we do not assume any duty to update in the future any forward-looking statements made today. Of course, any forward-looking statements involve risks and uncertainties, and our actual results could differ materially from those anticipated by any forward-looking statements that we make today. Additional information concerning factors that could affect our business and financial results is included in our most recent annual report on Form 10-K with the Securities and Exchange Commission and in other

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.